Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

85.40USD
29 Sep 2016
Change (% chg)

$-1.34 (-1.54%)
Prev Close
$86.74
Open
$86.86
Day's High
$87.45
Day's Low
$85.06
Volume
1,526,479
Avg. Vol
1,480,838
52-wk High
$89.27
52-wk Low
$64.95

Latest Key Developments (Source: Significant Developments)

Medtronic sees fy 2017 non-gaap EPS $4.60-$4.70
Tuesday, 31 May 2016 06:49am EDT 

Medtronic Plc : Q4 gaap earnings per share $0.78 . Q4 revenue $7.6 billion, up 4 percent . Qtrly restorative therapies group revenue $1.875 billion increased 1 percent, or 3 percent on a constant currency basis . Medtronic plc says expects a negative impact from foreign currency in fiscal year 2017 of about $25 to $75 million based on current exchange rates . Medtronic plc qtrly cvg worldwide revenue revenue of $2.736 billion increased 5 percent . Fy2017 earnings per share view $4.70 -- Thomson Reuters I/B/E/S . In fy 2017, expects constant currency revenue growth to be in upper-half of mid-single digit range, which is in range of 5 to 6 percent . Q4 non-gaap earnings per share $1.27 . Q4 earnings per share view $1.26, revenue view $7.49 billion -- Thomson Reuters I/B/E/S . Sees fy 2017 non-gaap earnings per share $4.60 to $4.70 . Sees fy 2017 non-gaap earnings per share $4.60 to $4.70 . Spine q4 revenue of $737 million declined 1 percent, or was flat on a constant currency basis .Fy2017 revenue view $29.67 billion -- Thomson Reuters I/B/E/S.  Full Article

Smith & Nephew sells gynaecology unit to Medtronic
Wednesday, 18 May 2016 08:00am EDT 

Smith & Nephew Plc : Divestment and share buy-back . Signed a definitive agreement to divest its gynaecology business to Medtronic Plc (NYSE:MDT) for $350 million. . Gynaecology delivered revenue of $56 million in 2015, representing a little over 1% of group revenue. . Transaction is expected to be broadly neutral to adjusted earnings ('EPSA') in 2017, after share buy-back, . Share buy back is expected to commence shortly after completion in July 2016 . Proceeds will be returned to shareholders through a $300 million share buy-back programme. . Gross proceeds are before tax and costs. . Is expected that majority of gynaecology employees will join Medtronic . Davis Polk & Wardwell Llp served as counsel to Smith & Nephew and Ondra Partners acted as financial advisor. .Divestment and share buy-back.  Full Article

Mazor Robotics enters into two strategic agreements with Medtronic
Wednesday, 18 May 2016 04:00am EDT 

Mazor Robotics Ltd : Entered into two strategic agreements with medtronic plc . Second agreement is for an equity investment by medtronic in mazor . One agreement is for co-development and, upon meeting certain milestones, potential global distribution of certain mazor products . Medtronic to purchase from co newly issued securities representing four percent of co's outstanding share capital on a fully diluted basis .Medtronic, at its sole discretion, may cap each of second and third tranches at $20 million each.  Full Article

Medtronic PLC appoints Karen L. Parkhill as CFO
Wednesday, 4 May 2016 08:30am EDT 

Medtronic PLC:Appoints Karen L. Parkhill as executive vice president and chief financial officer.Says Parkhill will succeed Gary L. Ellis in the CFO role.  Full Article

Medtronic PLC announces Worldwide Voluntary Recall for Battery Pack in Covidien Oridion Labeled Capnostream 20 and Capnostream 20 - EUCLID Procurement
Friday, 22 Apr 2016 11:37am EDT 

Medtronic PLC:Monitors Medtronic is notifying customers worldwide of a voluntary recall for the battery pack used in its Covidien Oridion labeled Capnostream 20 and Capnostream 20p Patient Monitors.This voluntary recall is being conducted due to a battery manufacturing defect that may increase the risk of thermal damage in the battery pack.The scope of this recall includes battery pack model numbers 016400 and 010520.These packs were manufactured by a contract manufacturer between April 2014 and February 2016.Capnostream monitors are external (non-implantable) medical devices used to assess patients' respiratory status and identify changes in breathing.The prescription device is operated by trained healthcare professionals in a clinical setting and in the home.  Full Article

Medtronic PLC receives FDA approval for expanded indication trial in low-risk aortic stenosis patients
Monday, 22 Feb 2016 08:31am EST 

Medtronic PLC:Receives FDA approval for expanded indication trial in low-risk aortic stenosis patients.Says enrollment for the investigational device exemption (ide) trial is expected to begin during the spring of 2016.Says trial has a 2-year endpoint and allows for a one-year analysis for early FDA submission.  Full Article

Medtronic PLC updates capital allocation plans
Monday, 11 Jan 2016 12:30pm EST 

Medtronic PLC:Says executing incremental $5 billion share repurchase.Says tightening 2016 EPS guidance due to benefit of U.S. research and development tax credit.Says intends to return $5 billion of the $9.3 billion to its shareholders through share repurchases.Says share repurchases to be executed before the end of fiscal year 2018.Medtronic intends to use a majority of the remaining proceeds to either prepay existing debt or pay debt.  Full Article

Medtronic PLC announces cash dividend for third quarter
Friday, 11 Dec 2015 04:10pm EST 

Medtronic PLC:Says approved fiscal year 2016 third quarter cash dividend of $0.38 per ordinary share.Dividend is payable on January 15, 2016, to shareholders of record date on December 24.  Full Article

Medtronic PLC announces FDA approval of infuse® bone graft for three new spine surgery indications
Friday, 11 Dec 2015 08:30am EST 

Medtronic PLC:Medtronic announces FDA approval of infuse® bone graft for three new spine surgery indications.Says expects to begin marketing these expanded indications in early calendar year 2016.  Full Article

Medtronic PLC announces FDA approval for brain stimulation systems
Wednesday, 9 Dec 2015 08:00am EST 

Medtronic PLC:Medtronic announces FDA approval for the only full-body mr conditional deep brain stimulation systems.Says updated labeling allows greater patient access to mri, a critical diagnostic tool.  Full Article

BRIEF-Medtronic receives FDA clearance of TrailBlazer angled peripheral support catheter

* Medtronic receives FDA clearance of TrailBlazer angled peripheral support catheter